Metraipolis › archive › dc_166bd7c84cc4

Molecular Subtype-Associated Response to Cyclophosphamide-Epirubicin-Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective… — Europe PMC PMID:42279429

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279429
DOI
10.3390/cancers18111847
License (as archived)
solo-consultazione
Archived
2026-10-31T19:17:43.888Z
SHA-256 of the archived text
ebb53fe31e83914e79e30790be9ecc1c29448e14a9537f6fbfae6820f8b47d51
Stable URL of this page
https://metraipolis.com/documento/dc_166bd7c84cc4

How to cite

Molecular Subtype-Associated Response to Cyclophosphamide-Epirubicin-Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective… — Europe PMC PMID:42279429 — Europe PMC (en), https://europepmc.org/article/MED/42279429 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_166bd7c84cc4 (Metraipolis archive dc_166bd7c84cc4, sha256 ebb53fe31e83914e79e30790be9ecc1c29448e14a9537f6fbfae6820f8b47d51)
BibTeX
@misc{dc166bd7c84cc4,
  title = {Molecular Subtype-Associated Response to Cyclophosphamide-Epirubicin-Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective… — Europe PMC PMID:42279429},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279429},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_166bd7c84cc4; sha256 ebb53fe31e83914e79e30790be9ecc1c29448e14a9537f6fbfae6820f8b47d51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279429. Agents can read the archived copy with the MCP tool read_document.